According to research report clinical microbiology market is expected to reach USD 4.95 billion by 2023 from USD 3.42 billion in 2017, at a CAGR of 6.4% during the forecast period.
This research study involves the extensive use of secondary sources, directories, and databases (such as World Health Organization, Food and Drug Administration, The World Bank, Organisation for Economic Co-operation and Development (OECD), and the American Society of Microbiology), to identify and collect information useful for this technical, market-oriented, and financial study of the clinical microbiology market. In-depth interviews were conducted with various primary respondents, including subject-matter experts (SMEs), C-level executives of key market players, and industry consultants to obtain and verify qualitative and quantitative information and to assess market prospects.
This research study involves the extensive use of secondary sources, directories, and databases (such as World Health Organization, Food and Drug Administration, The World Bank, Organisation for Economic Co-operation and Development (OECD), and the American Society of Microbiology), to identify and collect information useful for this technical, market-oriented, and financial study of the clinical microbiology market. In-depth interviews were conducted with various primary respondents, including subject-matter experts (SMEs), C-level executives of key market players, and industry consultants to obtain and verify qualitative and quantitative information and to assess market prospects.
As of 2017, bioMérieux SA (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), held the leading position in the global clinical microbiology market. These companies adopted product launches and enhancements; acquisitions; partnerships and collaborations; and expansions as their key growth strategies in the past four years. Some of the prominent players operating in the global clinical microbiology market include Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche AG (Switzerland), Bruker Corporation (US), Hologic, Inc. (US), among others.
Stakeholders
- Manufacturers of microbiological testing/clinical microbiology products
- Healthcare service providers
- Manufacturers of pharmaceutical products
- Clinical research organizations (CROs)
- Clinical Testing laboratories
- Food and Beverages Manufacturing Companies
- Manufacturers of petrochemical and biofuel products
- Oil & gas production and distribution companies
- Gas operators, distributors, and regulators
- Environmental monitoring committees
- Manufacturers of environmental monitoring products
- National & regional pollution control boards and organizations
- Research laboratories and academic institutes
- Market research and consulting firm
Scope of the Report
This report categorizes the global microbiology testing/clinical microbiology market into the following segments and subsegments:
Global Microbiology Testing Market, by Application
- Pharmaceutical Applications
- Clinical Applications
- Food Testing Applications
- Energy Applications
- Chemical and Material Manufacturing Applications
- Environmental Applications
No comments:
Post a Comment